Plain-English translation of NCT06717815 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lupus Nephritis research guide →Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing a new medication called to see if it can safely treat lupus nephritis—a serious kidney condition that develops in some lupus patients. Researchers will give patients different doses of the medication and carefully monitor their kidney function, safety, and how their immune system responds. The goal is to find the best dose and confirm that the medication helps protect kidney health.
Lupus nephritis can cause permanent kidney damage and kidney failure, and current treatment options don't work well for all patients. This trial exists to find a new treatment that might control the disease better and protect kidney function with fewer side effects.
You likely qualify if…
You likely don't qualify if…
If you enroll, you'll first go through a 4-week screening period to confirm you meet all requirements. Then you'll take the medication by mouth twice a day for 4 weeks, with regular visits to the clinic for blood tests, urine tests, and check-ins about how you're feeling. You'll be in one of three groups receiving different doses, and doctors will carefully watch for any side effects before moving the next group to a higher dose. The entire study takes about 8 weeks from start to finish.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
China